Drug Shortage Report for ADENOSINE INJECTION

Last updated on 2020-04-27 History
Report ID 105197
Drug Identification Number 02457482
Brand name ADENOSINE INJECTION
Common or Proper name Adenosine Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ADENOSINE
Strength(s) 3MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 4 mL
ATC code C01EB
ATC description OTHER CARDIAC PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-03
Estimated end date 2020-04-22
Actual end date 2020-04-24
Shortage status Resolved
Updated date 2020-04-27
Company comments Available Apr. 22, 2020
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-04-27 French Compare
v7 2020-04-27 English Compare
v6 2020-04-02 French Compare
v5 2020-04-02 English Compare
v4 2020-04-02 English Compare
v3 2020-02-04 English Compare
v2 2020-02-03 French Compare
v1 2020-02-03 English Compare